Validity and Reliability Study of the Pain Indicator Behavior Scale-Brain Damage (ESCID-DC)

Launched by CANDELAS LOPEZ LOPEZ · May 18, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a tool called the Pain Indicator Behavior Scale (ESCID), specifically adapted for patients with acquired brain injuries. The goal is to see if this scale can reliably measure pain in patients who cannot communicate verbally or through movement. By doing this, researchers hope to improve how we understand and treat pain in individuals with brain damage.

To participate in this study, individuals must be at least 18 years old and unable to communicate verbally or physically. They should also have an artificial airway (a tube that helps them breathe). Family members or representatives will need to give consent for participation. The trial is currently recruiting participants, and those who join can expect to help researchers gather important information that could lead to better pain management for patients with similar conditions in the future. It’s important to note that individuals with certain past medical conditions, such as severe brain injuries or dementia, won’t be eligible to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age equal to or greater than 18 years.
• • 2. Inability to communicate verbally or motor.
• • 3. Have a artificial airway.
• • 4. Informed consent of the family member or representative of the patient.
• Exclusion Criteria:
• • 1. Previous pathology of cognitive impairment.
• • 2. Previous brain injury.
• • 3. Previous psychiatric disorder.
• • 4. Previous dementia.
• • 5. Previous chronic substance abuse.
• • 6. Previous chronic diabetics.
• • 7. Previous spinal cord injury.
• • 8. Previous severe polyneuropathy (diagnosed or suspected).
• • 9. Confirmed diagnosis of brain death.
• • 10. Continuous infusion of muscle relaxants and / or barbiturate coma.
• • 11. Level of deep sedation (RASS -5).